Organogenesis Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68621F1021
USD
2.58
-0.06 (-2.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
225.61
150.86
101.00
86.69
126.66
115.18
130.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
225.61
150.86
101.00
86.69
126.66
115.18
130.23
Raw Material Cost
49.54
43.24
34.28
30.01
35.15
31.80
33.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.47
0.62
Selling and Distribution Expenses
93.16
72.24
66.94
66.01
67.44
65.38
70.18
Other Expenses
1.03
1.32
1.04
1.06
1.15
0.99
1.50
Total Expenditure (Excl Depreciation)
152.99
128.70
111.62
106.66
114.11
107.52
119.37
Operating Profit (PBDIT) excl Other Income
72.6
22.200000000000003
-10.600000000000001
-20
12.5
7.7
10.9
Other Income
0.14
0.43
0.74
0.96
0.03
0.05
-0.03
Operating Profit (PBDIT)
72.38
29.59
-3.22
-12.72
16.67
12.71
15.24
Interest
0.00
0.00
0.00
0.00
0.00
0.47
0.62
Exceptional Items
-1.94
-1.44
-1.96
-6.78
0.00
0.00
-22.80
Gross Profit (PBDT)
176.07
107.63
66.72
56.69
91.51
83.38
96.63
Depreciation
7.01
6.99
6.66
6.28
6.42
6.42
6.36
Profit Before Tax
63.43
21.16
-11.83
-25.78
10.25
5.82
-14.54
Tax
19.73
-0.41
-2.44
-6.94
2.58
-6.51
2.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
43.70
21.57
-9.39
-18.84
7.67
12.33
-17.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
43.70
21.57
-9.39
-18.84
7.67
12.33
-17.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
43.70
21.57
-9.39
-18.84
7.67
12.33
-17.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
300.13
255.13
233.24
242.90
262.90
278.55
263.50
Earnings per share (EPS)
0.27
0.11
-0.1
-0.17
0.06
0.09
-0.13
Diluted Earnings per share
0.27
0.11
-0.1
-0.17
0.06
0.09
-0.13
Operating Profit Margin (Excl OI)
28.91%
14.69%
-10.51%
-23.03%
8.07%
5.42%
6.84%
Gross Profit Margin
31.22%
18.66%
-5.13%
-22.49%
13.16%
10.63%
-6.28%
PAT Margin
19.37%
14.3%
-9.3%
-21.74%
6.06%
10.71%
-13.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 49.50% vs 49.41% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 102.31% vs 329.79% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 147.26% vs 830.00% in Sep 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Organogenesis Holdings, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
225.61
34.99
190.62
544.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
225.61
34.99
190.62
544.78%
Raw Material Cost
49.54
18.08
31.46
174.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
1.41
-1.41
-100.00%
Selling and Distribution Expenses
93.16
18.21
74.95
411.59%
Other Expenses
1.03
-0.14
1.17
835.71%
Total Expenditure (Excl Depreciation)
152.99
36.30
116.69
321.46%
Operating Profit (PBDIT) excl Other Income
72.62
-1.30
73.92
5,686.15%
Other Income
0.14
0.00
0.14
Operating Profit (PBDIT)
72.38
1.91
70.47
3,689.53%
Interest
0.00
1.41
-1.41
-100.00%
Exceptional Items
-1.94
-8.45
6.51
77.04%
Gross Profit (PBDT)
176.07
16.91
159.16
941.22%
Depreciation
7.01
3.22
3.79
117.70%
Profit Before Tax
63.43
-11.16
74.59
668.37%
Tax
19.73
-1.65
21.38
1,295.76%
Provisions and contingencies
0
0
0.00
Profit After Tax
43.70
-9.51
53.21
559.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
43.70
-9.51
53.21
559.52%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
43.70
-9.51
53.21
559.52%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
300.13
82.11
218.02
265.52%
Earnings per share (EPS)
0.27
-0.15
0.42
280.00%
Diluted Earnings per share
0.27
-0.15
0.42
280.00%
Operating Profit Margin (Excl OI)
28.91%
-3.72%
0.00
32.63%
Gross Profit Margin
31.22%
-22.69%
0.00
53.91%
PAT Margin
19.37%
-27.18%
0.00
46.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 22.56 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 49.50% vs 49.41% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 78.06% vs 27.08% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.37 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 102.31% vs 329.79% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 467.53% vs 1,383.33% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.22 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 147.26% vs 830.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 334.94% vs 137.14% in Dec 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.91%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024